• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Introduction to 6-bromo-1-methylquinolin-1-ium iodide (CAS No. 32596-82-0)

6-bromo-1-methylquinolin-1-ium iodide, identified by its Chemical Abstracts Service (CAS) number 32596-82-0, is a significant compound in the realm of organic chemistry and pharmaceutical research. This organometallic derivative of quinoline has garnered attention due to its versatile applications in medicinal chemistry, material science, and catalysis. The compound’s unique structural features, including a brominated and methylated quinoline core, make it a valuable intermediate in the synthesis of more complex molecules, particularly in the development of novel therapeutic agents.

The quinoline scaffold, a nitrogen-containing heterocycle, is well-documented for its pharmacological properties and biological relevance. Quinoline derivatives have been extensively studied for their antimicrobial, antimalarial, and anticancer activities. The introduction of bromine and methyl substituents into the quinoline ring enhances the compound’s reactivity and functionalization potential, making it an attractive candidate for further chemical modifications. The cationic nature of the 6-bromo-1-methylquinolin-1-ium iodide ion, stabilized by the iodide counterion, contributes to its solubility in polar organic solvents, facilitating its use in various synthetic protocols.

In recent years, 6-bromo-1-methylquinolin-1-ium iodide has been explored in the context of metal-organic frameworks (MOFs) and coordination chemistry. Its ability to act as a ligand or building block in supramolecular assemblies has opened new avenues for designing functional materials with applications in gas storage, separation technologies, and catalysis. The bromine atom’s electrophilic character allows for cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing biaryl and heteroaryl systems. These transformations are crucial in pharmaceutical synthesis, where complex molecular architectures are often required.

The pharmaceutical industry has shown particular interest in 6-bromo-1-methylquinolin-1-ium iodide due to its potential as a precursor for kinase inhibitors and other small-molecule drugs. Kinases are enzymes involved in numerous cellular processes, including signal transduction and cell division, making them key targets for therapeutic intervention. By modifying the quinoline core with functional groups like bromine and methyl groups, researchers can fine-tune the binding affinity and selectivity of their compounds against specific kinase isoforms. Preliminary studies suggest that derivatives of 6-bromo-1-methylquinolin-1-ium iodide exhibit promising inhibitory activity against certain cancer-related kinases.

Additionally, the compound’s fluorescence properties have been investigated for potential applications in bioimaging and sensors. Quinoline derivatives often exhibit strong emission characteristics when excited by UV light, making them suitable for detecting biological molecules or environmental pollutants. The bromine substituent can be further functionalized to introduce additional photophysical properties or to enhance interactions with biological targets. This dual functionality—both as a synthetic intermediate and a fluorescent probe—positions 6-bromo-1-methylquinolin-1-ium iodide as a multifaceted tool in modern chemical research.

The synthesis of 6-bromo-1-methylquinolin-1-ium iodide typically involves the bromination of 1-methylquinoline followed by salt formation with an iodide counterion. Advanced synthetic methodologies have been developed to improve yield and purity, including catalytic bromination techniques that minimize side reactions. These advancements are essential for ensuring that the compound meets the stringent requirements of pharmaceutical applications. Furthermore, green chemistry principles have been applied to optimize synthetic routes, reducing waste generation and energy consumption without compromising efficiency.

In conclusion,6-bromo-1-methylquinolin-1-ium iodide (CAS No. 32596-82-0) is a versatile compound with broad applications across multiple scientific disciplines. Its role as a synthetic intermediate in drug development, material science, and catalysis underscores its importance in contemporary research. As new methodologies emerge for functionalizing quinoline derivatives,6-bromo-1-methylquinolin-1-ium iodide will likely continue to play a pivotal role in advancing both academic and industrial chemical projects.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)